The top three companies—Express Scripts, CVS Health, and Walgreen—accounted for 56% of revenues from pharmacy-dispensed specialty drugs. Over the past few years, however, marketplace and business changes have reduced their share.
To learn more about specialty pharmacy and meet the industry’s key players, be sure to attend the 2015 sPCMA Business Forum and the 2015 Armada Specialty Pharmacy Summit. I’ll be at both, so be sure to say hi!
As I describe in 2014's Top Pharmacies: Specialty Shifts Industry Leadership, many of the biggest U.S. pharmacies by revenue are now central-fill, mail pharmacies operated by pharmacy benefit managers (PBMs). Specialty drugs account for 30% or more of revenues at these pharmacies.
Here’s our list of the top pharmacies. The table appears in our new 2014–15 Economic Report on Retail, Mail, and Specialty Pharmacies.
[Click to Enlarge]
Here are some highlights of the 2014 market share figures:
- CVS Health’s specialty pharmacy dispensing revenues grew by 28%, to an estimated $20.5 billion. This figure includes revenues from the Caremark specialty pharmacy and from CVS retail pharmacies. It excludes infusion revenues from Coram, which it acquired in December 2013. Caremark’s specialty pharmacy is the exclusive specialty pharmacy provider for certain employer PBM clients.
- We estimate that revenues at Express Scripts’ Accredo and FreedomFP specialty pharmacies were lower than last year’s figure, due to smaller claims volume.
- Walgreens remains the third-largest specialty pharmacy, because of its many strategic acquisitions. We estimate that about $2 billion of its specialty drug revenues comes from prescriptions dispensed at Walgreens retail drugstores.
- UnitedHealth’s OptumRx has become a much larger specialty pharmacy ever since it took over UnitedHealth’s commercial business from Medco. Some of these specialty revenues had been included with the combined Express Scripts/Medco pharmacy. UnitedHealthcare is also a large sponsor of Medicare Part D prescription drug plans. See In 2015, 8 of 10 Seniors Choose Preferred Pharmacy Networks in Medicare (Plus: Which Plans Won).
- Diplomat Pharmacy, the largest independent specialty pharmacy, became a public company in October 2014. I'll review Diplomat’s latest financial results in an upcoming post.
- BriovaRx, the specialty pharmacy of PBM Catamaran, recently disclosed that its revenues were about $2 billion in 2014. This figure excludes the acquisition of Salveo Specialty Pharmacy, which will add at least $400 million in revenues.
Specialty drugs are poised for another year of tremendous growth. As Phil Hagerman, CEO of Diplomat Pharmacy, said recently: “Specialty pharmacy IS the new pharmacy.” The size and growth of these 10 companies prove it.